If you've been diagnosed with mildly low thyroid function and you're an older adult, you may not get symptom relief from the commonly prescribed medication, according to new research. It's routine that people diagnosed with mildly low thyroid function, which doctors call subclinical hypothyroidism, are prescribed levothyroxine Synthroid, Levoxyl, others. However, a new study that evaluated more than adults, all over age 65 and on average age 74 finds that the medication did not have a consistent beneficial effect on their thyroid-related symptoms such as fatigue and tiredness. While prescribing the medication is routine, ''what this study suggests is, that's not really evidence-based practice'' in older adults, says study co-investigator Douglas Bauer, MD, professor of medicine, epidemiology and biostatistics at the University of California San Francisco School of Medicine. Guidelines about how to treat the condition should be updated, says the study's leader, David Stott, MD, the Cargill chair of geriatric medicine at the University of Glasgow, in a press release.
Regular Aspirin Use May Increase Older People’s Risk of Dying from Cancer
Thyroid Cancer: 5 Things Young Women Need To Know | SELF
Patients older than age 45 with thyroid cancer that has spread to neck lymph nodes have long been considered at higher risk of dying, but the same has not been true for younger patients. Now researchers at the Duke Cancer Institute and the Duke Clinical Research Institute have found that younger thyroid cancer patients with lymph node involvement are also at increased risk of dying, contrary to current beliefs and staging prognostic tools that classify young patients as having low-risk disease. The finding, published this week in the Journal of Clinical Oncology , comes at a time when the American Joint Committee on Cancer is working to revise the staging criteria for all cancers, including thyroid cancer, which is the fastest-increasing malignancy among both men and women in the U. Sosa said the current system classifies cancers in four stages among patients over the age of 45, with Stage 1 patients having the best prognosis and Stage 4 having the worst. For patients under 45, there are currently only two stages, and both are typically associated with favorable overall prognoses. Sosa and her colleagues said they sought to explore whether the current staging system accurately reflects the impact of lymph node involvement on survival in younger patients.
5 Things All Young Women Need To Know About Thyroid Cancer
Survivors of thyroid cancer can be affected by a number of health problems, but often their greatest concern is facing another cancer. Cancer that comes back after treatment it is called a recurrence. But some cancer survivors may develop a new, unrelated cancer later.
The stage of a cancer tells you about its size and whether it has spread. Doctors use the number staging system and the TNM staging system. The number staging system usually groups cancers into 4 groups, from stage 1 to 4. Papillary and follicular thyroid cancer are classified as differentiated thyroid cancers.